Immunome Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	272.64	143.35	98.68	20.32	49.23	39.77
Short-Term Investments	-	73.95	39.46	-	-	-
Cash & Short-Term Investments	272.64	217.3	138.14	20.32	49.23	39.77
Cash Growth	13.54%	57.30%	579.73%	-58.72%	23.80%	1463.74%
Accounts Receivable	-	-	-	-	1.64	-
Other Receivables	-	-	-	0.85	2.67	0.85
Receivables	-	-	-	0.85	4.31	0.85
Prepaid Expenses	7.29	4.04	6.56	1.03	2.51	2.28
Other Current Assets	-	-	-	0.45	0.59	-
Total Current Assets	279.92	221.34	144.7	22.65	56.64	42.89
Property, Plant & Equipment	14.69	14.39	3.64	0.97	0.86	1.53
Long-Term Deferred Charges	-	-	-	0.33	0.33	-
Other Long-Term Assets	4.77	4.51	0.2	0.1	0.1	0.1
Total Assets	299.38	240.24	148.54	24.05	57.93	44.53
Accounts Payable	6.15	14.19	3.31	2.4	3.08	1.19
Accrued Expenses	23.56	30.98	6.98	4.62	4.31	1.27
Current Portion of Long-Term Debt	-	-	-	-	-	0.48
Current Portion of Leases	-	0.06	0.31	0.23	-	-
Current Unearned Revenue	-	6.94	10.49	-	-	-
Other Current Liabilities	1.74	2.14	0.73	0.09	2.34	0.1
Total Current Liabilities	31.45	54.31	21.83	7.33	9.73	3.04
Long-Term Debt	-	-	-	-	-	0.13
Long-Term Leases	4.01	4.77	1.34	0.06	-	-
Long-Term Unearned Revenue	-	-	5.49	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.01	0.01
Total Liabilities	35.46	59.08	28.66	7.39	9.74	3.18
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	922.17	696.87	342.66	132.65	127.29	95.74
Retained Earnings	-658.26	-515.77	-222.81	-116	-79.11	-54.39
Comprehensive Income & Other	-	0.06	0.02	-	-	-
Total Common Equity	263.92	181.17	119.88	16.65	48.19	41.35
Shareholders' Equity	263.92	181.17	119.88	16.65	48.19	41.35
Total Liabilities & Equity	299.38	240.24	148.54	24.05	57.93	44.53
Total Debt	4.01	4.83	1.65	0.29	-	0.61
Net Cash (Debt)	268.63	212.47	136.49	20.03	49.23	39.15
Net Cash Growth	13.15%	55.67%	581.37%	-59.31%	25.74%	1878.42%
Net Cash Per Share	3.39	3.62	6.88	1.65	4.27	11.55
Filing Date Shares Outstanding	91.71	86.95	59.69	12.22	12.13	10.66
Total Common Shares Outstanding	91.71	64.46	43.25	12.13	12.11	10.63
Working Capital	248.48	167.03	122.87	15.32	46.91	39.86
Book Value Per Share	2.88	2.81	2.77	1.37	3.98	3.89
Tangible Book Value	263.92	181.17	119.88	16.65	48.19	41.35
Tangible Book Value Per Share	2.88	2.81	2.77	1.37	3.98	3.89
Machinery	-	9.93	5.75	3.94	3.69	3.62
Construction In Progress	-	3.3	-	-	-	-
Leasehold Improvements	-	1.64	0.23	0.19	0.19	0.19

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q